First Citizens Financial Corp Nymox Pharmaceutical Corp Transaction History
First Citizens Financial Corp
- $189 Million
- Q3 2024
A detailed history of First Citizens Financial Corp transactions in Nymox Pharmaceutical Corp stock. As of the latest transaction made, First Citizens Financial Corp holds 35,100 shares of NYMX stock, worth $16,497. This represents 0.01% of its overall portfolio holdings.
Number of Shares
35,100
Previous 35,100
-0.0%
Holding current value
$16,497
Previous $16,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding NYMX
# of Institutions
6Shares Held
150KCall Options Held
0Put Options Held
0-
Df Dent & CO Inc Baltimore, MD75KShares$35,2500.0% of portfolio
-
Gofen & Glossberg LLC25KShares$11,7500.0% of portfolio
-
Cubic Asset Management, LLC10KShares$4,7000.0% of portfolio
-
Bdo Wealth Advisors, LLC Jacksonville, FL4.7KShares$2,2090.0% of portfolio
-
Steward Financial Group LLC100Shares$470.0% of portfolio
About NYMOX PHARMACEUTICAL CORP
- Ticker NYMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 91,265,000
- Market Cap $42.9M
- Description
- Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...